ECONOMIC EVALUATION OF NAB-PACLITAXEL PLUS GEMCITABINE VERSUS GEMCITABINE ALONE FOR THE MANAGEMENT OF METASTATIC PANCREATIC CANCER IN GREECEVALUE IN HEALTHIF62014-11-013OAAI
Economic Evaluation Of In-Vitro Fertilization As Assisted Reproductive Technique In Management Of Infertility In The Netherlands: A Cost-Effectiveness Model Based On A Long Down-Regulation ProtocolVALUE IN HEALTHIF62014-05-010OAAI
SAFETY AND TOLERABILITY OF AZACITIDINE IN PATIENTS WITH INTERMIDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES IN GREECEA RETROSPECTIVE CHART REVIEW STUDY FOR THE DAILY PRACTISEVALUE IN HEALTHIF62014-05-010OAAI
THE OVERALL RESPONSE RATE OF AZACITIDINE IN PATIENTS WITH INTERMIDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE CHART REVIEW STUDY FROM GREECEVALUE IN HEALTHIF62014-05-010OAAI
THE COST OF PRODUCING A UNIT OF BLOOD IN HOSPITALS: A NATIONWIDE ECONOMIC ANALYSIS FOR THE CASE OF GREECEVALUE IN HEALTHIF62013-11-010OAAI
COST BENEFIT ANALYSIS ON THE LONG TERM EFFECTS OF IN VITRO FERTILIZATION (IVF) IN GREECE: AN ANALYSIS BASED ON A LIFETIME MODELVALUE IN HEALTHIF62012-11-010OAAI
ECONOMIC EVALUATION OF LENALIDOMIDE IN THE MANAGEMENT OF PREVIOUSLY TREATED MULTIPLE MYELOMA (PTMM) PATIENTS IN GREECEVALUE IN HEALTHIF62012-06-012OAAI
ECONOMIC EVALUATION OF DARBEPOETIN ALPHA IN THE MANAGEMENT OF PATIENTS WITH CHEMOTHERAPY INDUCED ANEMIA (CIA) IN GREECEVALUE IN HEALTHIF62011-11-011OAAI
A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS WITH ATHEROTHROMBOSIS IN GREECEVALUE IN HEALTHIF62011-11-010OAAI
ECONOMIC EVALUATION OF RECOMBINANT HUMAN FSH IN COMPARISON WITH URINARY HMG IN ASSISTED REPRODUCTION IN THE GREEK SETTINGVALUE IN HEALTHIF62011-11-011OAAI
ECONOMIC EVALUATION OF PANITUMUMAB AND CETUXIMAB IN THE TREATMENT OF PATIENTS WITH EGFR EXPRESSING MCRC WITH NON-MUTATED (WILD-TYPE) KRAS IN GREECE: A COST MINIMIZATION ANALYSISVALUE IN HEALTHIF62011-11-010OAAI
ECONOMIC EVALUATION OF GEFITINIB FOR FIRST-LINE TREATMENT OF EGFR MUTATION POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS IN GREECEVALUE IN HEALTHIF62011-11-012OAAI
A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN PATIENTS WITH NON STABLE ACUTE CORONARY SYNDROME IN GREECEVALUE IN HEALTHIF62011-11-010OAAI
ECONOMIC EVALUATION IN THE POSTOPERATIVE MANAGEMENT OF COLORECTAL CANCER PATIENTS IN GREECEVALUE IN HEALTHIF62008-11-010OAAI